The American Kratom Association: Protecting Kratom Consumers
Contact Michigan Senate
〰️
Contact Michigan Senate 〰️
YOU CAN PROTECT KRATOM CONSUMERS BY CONTACTING YOUR CONGRESSIONAL REPRESENTATIVES
SIMPLY USE THE FORMS TO CALL AND EMAIL YOUR STATE AND DISTRICT REPRESENTATIVES
All you need to do is share your story to make a difference!
Why does protecting kratom matter?
Watch and see why Americans like Michael and millions of others care so much about protecting kratom access
Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) thinks we should be studying kratom – not classifying it as a Schedule I drug. Dr. Volkow points to exciting new basic science that “point toward the potential of this drug [kratom] in pain research as well as the need for further research on the pharmacology of kratom’s constituents, their toxicity and potential value in the treatment of Opioid Use Disorder (OUD)”
-Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA)
https://www.drugabuse.gov/about-nida/noras-blog/2020/01/reviewing-nidas-2019-achievements-looking-to-future